Financials
值 202020212022202320242025 TTM 销售/总务/管理费用 188.27 M567 M1.13 B1.75 B1.32 B1.15 B 979 M 研发 1.37 B1.99 B3.29 B4.84 B4.54 B3.13 B 2.92 B 营业收入 -763.14 M13.3 B9.42 B-4.24 B-3.94 B-3.07 B -3.41 B 营业外收入合计 -53.84 M-65 M124 M323 M381 M365 M 331 M 利息支出,净利息资本化 9.89 M17 M29 M38 M24 M3 M — 营业外收入,不包括利息支出 -57.65 M-53 M140 M409 M444 M370 M 353 M 非经常性收入/支出 -6.08 M-29 M-45 M-124 M-87 M-8 M -22 M 税前收入 -744.51 M13.29 B9.57 B-3.94 B-3.61 B-2.77 B -3.14 B 收益中的权益 ———-35 M-52 M-8 M -2 M 税收 2.55 M1.08 B1.21 B772 M-46 M54 M 56 M 非控股/少数股权 —————— — 税后其他收入/支出 ——-28 M-7 M-60 M-77 M -81 M 终止经营前净收入 -747.06 M12.2 B8.36 B-4.71 B-3.56 B-2.82 B -3.19 B 已终止经营 —————— — 净利润 -747.06 M12.2 B8.36 B-4.71 B-3.56 B-2.82 B -3.19 B 稀释调整 0————— — 优先股息 0————— — 普通股股东可获得的稀释净收益 -747.06 M12.2 B8.36 B-4.71 B-3.56 B-2.82 B -3.19 B 每股基本收益(基本 EPS) —30.3121.26-12.33-9.28-7.26 -8.14 稀释每股收益(稀释 EPS) —28.2920.12-12.33-9.28-7.26 -8.14 平均流通基本股 —403 M394 M382 M384 M389 M — 稀释流通股 —431 M416 M382 M384 M389 M — 息税折旧摊销前利润 -731.89 M13.53 B9.77 B-3.62 B-3.76 B-2.86 B -3.18 B 息税前利润 -763.14 M13.3 B9.42 B-4.24 B-3.94 B-3.07 B -3.41 B 营业成本 7.93 M2.62 B5.42 B4.69 B1.46 B868 M 1.73 B 其他销售成本 ——1.92 B2.34 B555 M315 M 301 M 折旧摊销(现金流) 31.25 M232 M348 M617 M185 M211 M 229 M
新闻
美国股市收低;截至收盘道琼斯工业平均指数下跌1.72%
Moderna在Barclays大会上的发言:战略增长与产品线扩张
美国股市收低;截至收盘道琼斯工业平均指数下跌1.61%
Moderna就专利诉讼与Arbutus和Genevant达成9.5亿美元和解协议
美股收盘:通胀担忧暂缓、油价持稳 科技股带动大盘重拾升势
美国股市上涨;截至收盘道琼斯工业平均指数上涨0.49%
Chardan重申Arbutus Biopharma股票评级,因与Moderna达成协议
Roivant Sciences股价创历史新高,达29.23美元
Moderna股价触及52周高点55.22美元
Moderna股价大涨,和解协议消除重大法律隐患
CrowdStrike、Nvidia和Moderna盘前上涨;Abercrombie & Fitch下跌
图表与思路
MRNA - Long-Term Technical Forecast
Weekly price is located above Ichimoku cloud in the bullish area of the chart for trying to cross the level at 81.36 to above for the strong bullish trend to be continuing. The price is on strong bullish breakout which is confirmed by Stochastic oscillator and Chinkou Span line. If the price breaks the 81.36 level to above on weekly close bar so the strong bullish trend will be continuing. If the price crosses the level at 73.28 to below so the secondary correction will be started. If the price breaks the support level at 43.90 to 36.66 to be crossed on weekly close bar so we may see the primary bearish reversal to be started on this W1 timeframe for example. Alternatively, the price will be on ranging to be near and above Ichimoku cloud waiting for direction. Trading Summary : bullish
0 The MRNA doesn’t have other trading ideas at this time
Browse ready-made trading ideas or select a symbol and create your own
Go to Charts and Trading Ideas